1. Age-related non-COVID vaccination errors

   News item 01 October 2022 Pages: 1 - 1

2. Colchicine poisoning due to overdose

   News item 01 October 2022 Pages: 2 - 2

3. FDA approves Pedmark for preventing cisplatin-induced hearing loss

   News item 01 October 2022 Pages: 3 - 3

4. Fluorouracil- and capecitabine-related dihydropyrimidine deficiency

   News item 01 October 2022 Pages: 4 - 4

5. Headache common after COVID-19 vaccination

   News item 01 October 2022 Pages: 5 - 5

6. Recommendations from 1st joint meeting of GACVS and ACSOMP

   News item 01 October 2022 Pages: 6 - 6

7. Dolutegravir-based ART increases weight gain versus NNRTIs

   Clinical study 01 October 2022 Pages: 7 - 7

8. Drug safety communications: understanding healthcare professionals' preferences and responses

   Clinical study 01 October 2022 Pages: 8 - 8

9. Fluoroquinolone-related tendonitis and tendon rupture

   Clinical study 01 October 2022 Pages: 9 - 9

10. Oral anticoagulants safer than VKAs in patients with AF at risk of falls

    Clinical study 01 October 2022 Pages: 10 - 10

11. Potentially inappropriate prescribing increases ADR costs

    Clinical study 01 October 2022 Pages: 11 - 11

12. Primary care medicines associated with acute kidney injury

    Clinical study 01 October 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 01 October 2022 Pages: 13 - 13

14. Acetazolamide/calcitonin/calcium-carbonate

    Case report 01 October 2022 Pages: 14 - 14

15. Aciclovir

    Case report 01 October 2022 Pages: 15 - 15

16. Ad26.cov2-s

    Case report 01 October 2022 Pages: 16 - 16

17. Adalimumab

    Case report 01 October 2022 Pages: 17 - 17

18. Adalimumab

    Case report 01 October 2022 Pages: 18 - 18

19. Adalimumab/infliximab/secukinumab

    Case report 01 October 2022 Pages: 19 - 19

20. Afatinib

    Case report 01 October 2022 Pages: 20 - 20

21. Aflibercept

    Case report 01 October 2022 Pages: 21 - 21

22. Aflibercept

    Case report 01 October 2022 Pages: 22 - 22

23. Alectinib

    Case report 01 October 2022 Pages: 23 - 23

24. Alectinib/ensartinib

    Case report 01 October 2022 Pages: 24 - 24

25. Alemtuzumab/glatiramer-acetate/interferon-beta-1a

    Case report 01 October 2022 Pages: 25 - 25

26. Alendronic-acid

    Case report 01 October 2022 Pages: 26 - 26

27. Alendronic-acid/anti-inflammatories/immunosuppressants

    Case report 01 October 2022 Pages: 27 - 27

28. Allopurinol

    Case report 01 October 2022 Pages: 28 - 28

29. Allopurinol/colchicine

    Case report 01 October 2022 Pages: 29 - 29

30. Alprazolam/antidepressants/mirtazapine

    Case report 01 October 2022 Pages: 30 - 30

31. Alprazolam/ethyl loflazepate

    Case report 01 October 2022 Pages: 31 - 31

32. Alprostadil/antiplatelets

    Case report 01 October 2022 Pages: 32 - 32

33. Amino-acids-mix

    Case report 01 October 2022 Pages: 33 - 33

34. Aminolevulinic-acid

    Case report 01 October 2022 Pages: 34 - 34

35. Aminophylline/anti-inflammatories

    Case report 01 October 2022 Pages: 35 - 35

36. Amiodarone/ivabradine/procainamide

    Case report 01 October 2022 Pages: 36 - 36

37. Amivantamab

    Case report 01 October 2022 Pages: 37 - 37

38. Amphotericin-B

    Case report 01 October 2022 Pages: 38 - 38

39. Amphotericin-b-liposomal/anidulafungin

    Case report 01 October 2022 Pages: 39 - 39

40. Ampicillin/piperacillin/tazobactam

    Case report 01 October 2022 Pages: 40 - 40

41. Angelicae radix/astragalus propinquus/atractylodes lancea/citrus reticulata/cinnamon/ginseng/paeonia/polygala senega/radix glycyrrhizae/rehmannia/schisandra/wolfiporia extensa/dexamethasone/remdesivir

    Case report 01 October 2022 Pages: 41 - 41

42. Anti-inflammatories/IL17A-protein-inhibitors

    Case report 01 October 2022 Pages: 42 - 42

43. Antiarrhythmics/β-adrenergic-receptor-antagonists

    Case report 01 October 2022 Pages: 43 - 43

44. Antiasthmatics/guaifenesin/nivolumab

    Case report 01 October 2022 Pages: 44 - 44

45. Antibacterials

    Case report 01 October 2022 Pages: 45 - 45

46. Antibacterials/antineoplastics

    Case report 01 October 2022 Pages: 46 - 46

47. Antibacterials/antivirals

    Case report 01 October 2022 Pages: 47 - 47

48. Antibacterials/carbamazepine/hydrocortisone

    Case report 01 October 2022 Pages: 48 - 48

49. Anticancers

    Case report 01 October 2022 Pages: 49 - 49

50. Antidepressants

    Case report 01 October 2022 Pages: 50 - 50